Journals / Turkish Journal of Gastroenterology / 2013 / Cilt: 24 - Sayı: 5

Conjugated hyperbilirubinemia in the neonatal intensive care unit

Yenidoğan yoğun bakım ünitesinde direkt hiperbilirubinemi

Pages
406–414
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early diagnosis and treatment may be cri- tical for favorable outcome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: To determine the underlying causes and short-term prognosis of patients with conjugated hyperbilirubinemia in a tertiary neonatal intensive care units.
📊
Key Findings & Data:Results: Of a total of 104 infants with conjugated hyperbilirubinemia (2.1%, 104/4915), 92 infants (56 full-term, 36 preterm) were enrolled in the study.
💡
Conclusion & Impact:Early diagnosis and treatment may be cri- tical for favorable outcome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background/aims: To determine the underlying causes and short-term prognosis of patients with conjugated hyperbilirubinemia in a tertiary neonatal intensive care units. Materials and Methods: We retrospectively analyzed the etiology, course, and short- term prognosis of conjugated hyperbilirubinemia observed in newborn infants in a tertiary neonatal intensive care units. Results: Of a total of 104 infants with conjugated hyperbilirubinemia (2.1%, 104/4915), 92 infants (56 full-term, 36 preterm) were enrolled in the study. Cholestatic jaundice as a sole finding on physical examination during admission was present in 15.2% infants, and conjugated hyperbilirubinemia developed within the first week of life in nearly half of the infants (51.1%). The most frequent cau- ses of conjugated hyperbilirubinemia within the first days of life were vascular/ischemic events, inspissated bile, and inherited me- tabolic disorders. The majority of the infants (80%) had also concomitant clinical disorders that might possibly contributed to the development of conjugated hyperbilirubinemia. The majority of the deaths (87%) were primarily related to serious perinatal events and genetic/inherited disorders. Bilirubin levels in the most of the survivors (87.1%) returned to normal within six months. Conc- lusions: Conjugated hyperbilirubinemia is not uncommon in neonatal intensive care unit. Etiology is often multifactorial and mo- re commonly arise from non-hepatic causes. Outcome depends on the underlying causes. Early diagnosis and treatment may be cri- tical for favorable outcome.

Özet

Giriş ve Amaç: Yenidoğan yoğun bakım ünitesinde konjüge hiperbilirubinemi saptanan bebeklerde altta yatan nedenlerin ve kısa dönem prognozun araştırılması. Gereç ve Yöntem: Yenidoğan yoğun bakım ünitesinde konjüge hiperbilirubinemi gözlenen bebek- lerin dosyaları retrospektif olarak incelendi. Etyolojik nedenler, klinik gidiş ve kısa dönem prognoz açısından tanımlayıcı istatis- tiksel analiz yapıldı. Bulgular: Konjüge hiperbilirubinemi saptanan 104 (2.1%, 104/4915) bebeğin 92'si (56 term, 36 preterm) ça- lışmaya alındı. Bebeklerin %15.2'sinde sarılık tek fizik muayene bulgusu idi. Bebeklerin hemen yarısında (%51.1) konjüge hiperbi- liruinemi yaşamın ilk haftasında gelişmişti ve bu ilk haftada konjuge hiperbilirubinemi gelişen bebeklerde en sık nedenler vaskü- ler/iskemik olaylar, koyulaşmış safra sendromu ve kalıtsal metabolik hastalıklardı. Bebeklerin çoğunda (%80) konjüge hiperbili- rubinemi gelişimine katkısı olabilecek ek klinik durum söz konusu idi. Ölümlerin çoğu (%87) ağır perinatal olay ve genetik/kalıt- sal bozukluk ile ilişkiliydi. Yaşayan bebeklerin çoğunda (%87.1) bilirubin seviyesi 6 ay içinde normal sınırlara geriledi. Sonuç: Konjuge hiperbilirubinemi yenidoğan yoğun bakım ünitelerinde ender olmayan bir durumdur. Etyoloji sıklıkla multifaktöriyeldir ve genellikle karaciğer dışı nedenlerden kaynaklanır. Prognoz altta yatan nedene bağlıdır. Erken tanı ve tedavi iyi prognoz açısın- dan önem taşır.

🔖

Cite This Article

MATERNİTY, S. U., İPEK, M. Ş., AYDIN, M., ZENCİROLU, A., GÖKÇE, S., OKUMUŞ, N. (2013). Conjugated hyperbilirubinemia in the neonatal intensive care unit. Turkish Journal of Gastroenterology, Cilt: 24 - Sayı: 5, 406–414. https://ajindex.com/articles/409590

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Suchy FJ. Approach to the infant with cholestasis. In: Suchy FJ, Sokol RJ, Balistreri WF (eds). Liver Disease in Children. 3rd ed. UK. Cambridge University Press, 2007; 29:179-89
  2. Haber B, Ferreira CT, Aw M, et al. Cholestasis Working Group. Cholestasis: current issues and plan for future. J Pediatr Gastroenterol Nutr 2008; 47:220-4
  3. Moyer V, Freese DK, Whitington PF, et al. Guideline for the evaluation of cholestatic jaundice in infants: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2004; 39:115-28
  4. Dick MC, Mowat AP. Hepatitis syndrome in infancy-an epidemiological survey with 10 year follow up. Arch Dis Child 1985; 60:512-6
  5. Danks DM, Campbell PE, Jack I, et al. Studies of the etiology of neonatal cholestasis and biliary atresia. Arch Dis Child 1977; 52:360-7
  6. De Bruyne R, Van Biervliet S, Vande Velde S, Van Winckel M. Clinical practice: neonatal cholestasis. Eur J Pediatr 2011; 170:279-84 7. Roberts EA. Jaundiced Baby. In: Kelly D, ed. Diseases of the Liver and Biliary System in Children. 3rd ed. UK: Blackwell Publishing, 2008; 57-106
  7. Tyler W, McKiernan PJ. Prolonged jaundice in the preterm infant- What to do, when and why. Curr Paediatr 2006; 16:43-50
  8. Brown DC, Halliday HL, McClure G. Cholestasis in a neonatal intensive care unit. Irish Med J 1991; 84:56-7
  9. Jacquemin E, Lykavieris P, Chaoui N, Hadchouel M, Bernard O. Transient neonatal cholestasis: origine and outcome. J Pediatr 1998; 133:563-7
  10. Tufano M, Nicastro E, Giliberti P, et al. Cholestasis in neonatal intensive care unit: incidence, etiology and management. Acta Paediatr 2009; 98:1756-61
  11. Vajro P, Amelio A, Stagni A, et al. Cholestasis in newborn infants with perinatal asphyxia. Acta Paediatr 1997; 86:895-8
  12. Herzog D, Chessex P, Martin S, Alvarez F. Transient cholestasis in newborn infants with perinatal asphyxia. Can J Gastroenterol 2003; 17:179-82
  13. Dosi PC, Raut AJ, Chelliah BP, et al. Perinatal factors underlying neonatal cholestasis. J Pediatr 1985; 106:471-4
  14. Tiker F, Tarcan A, Kilicdag H, Gurakan B. Early onset conjugated hyperbilirubinemia in newborn infants. Indian J Pediatr 2006; 73:409-12
  15. Shamir R, Maayan-Metzger A, Bujanover Y, et al. Liver enzyme abnormalities in gram-negative bacteremia of premature infants. Pediatr Infect Dis J 2000; 19:495-8
  16. Khalil S, Shah D, Faridi MM, et al. Prevalence and outcome of hepatobiliary dysfunction in ne